SYNERGISTIC BLOCKADE OF SOME DOPAMINE-MEDIATED BEHAVIORS BY (-)-SULPIRIDE AND SCH-23390 IN THE RAT

被引：25

作者：

DALLOLIO, R ^{[1
]}

RONCADA, P ^{[1
]}

VACCHERI, A ^{[1
]}

GANDOLFI, O ^{[1
]}

MONTANARO, N ^{[1
]}

机构：

[1] UNIV BOLOGNA,INST PHARMACOL,VIA IRNERIO 48,I-40126 BOLOGNA,ITALY

来源：

PSYCHOPHARMACOLOGY | 1989年 / 98卷 / 03期

关键词：

D O I：

10.1007/BF00451685

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：342 / 346

页数：5

共 22 条

[1] DOPAMINE D-1 RECEPTOR AGONISTS COMBINED WITH THE SELECTIVE D-2 AGONIST QUINPIROLE FACILITATE THE EXPRESSION OF ORAL STEREOTYPED BEHAVIOR IN RATS [J].

ARNT, J ;

HYTTEL, J ;

PERREGAARD, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 133 (02) :137-145

[2] ANTISTEREOTYPIC EFFECTS OF DOPAMINE D-1 AND D-2 ANTAGONISTS AFTER INTRASTRIATAL INJECTION IN RATS - PHARMACOLOGICAL AND REGIONAL SPECIFICITY [J].

ARNT, J .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 330 (02) :97-104

[3] BEHAVIORAL STIMULATION IS INDUCED BY SEPARATE DOPAMINE-D-1 AND DOPAMINE-D-2 RECEPTOR-SITES IN RESERPINE-PRETREATED BUT NOT IN NORMAL RATS [J].

ARNT, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (01) :79-88

[4]

BENAKIS A, 1976, European Journal of Drug Metabolism and Pharmacokinetics, V1, P51

[5] SCH-23390 ANTAGONISM OF A D-2 DOPAMINE AGONIST DEPENDS UPON CATECHOLAMINERGIC NEURONS [J].

BREESE, GR ;

MUELLER, RA .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (01) :109-114

[6] PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].

CHRISTENSEN, AV ;

ARNT, J ;

HYTTEL, J ;

LARSEN, JJ ;

SVENDSEN, O .

LIFE SCIENCES, 1984, 34 (16) :1529-1540

[7] THE PRODUCTION OF ASYMMETRY AND CIRCLING BEHAVIOR FOLLOWING UNILATERAL, INTRASTRIATAL ADMINISTRATION OF NEUROLEPTIC AGENTS - A COMPARISON OF ABILITIES TO ANTAGONIZE STRIATAL FUNCTION [J].

COSTALL, B ;

KELLY, ME ;

NAYLOR, RJ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 96 (1-2) :79-86

[8] DETECTION OF NEUROLEPTIC PROPERTIES OF CLOZAPINE, SULPIRIDE AND THIORIDAZINE [J].

COSTALL, B ;

NAYLOR, RJ .

PSYCHOPHARMACOLOGIA, 1975, 43 (01) :69-74

[9] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].

CREESE, I ;

BURT, DR ;

SNYDER, SH .

SCIENCE, 1976, 192 (4238) :481-483

[10]

DALLOLIO R, 1988, PSYCHOPHARMACOLOGY, V95, P381

← 1 2 3 →